Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression – 5 year results of a prospective study

[1]  J. Fung,et al.  Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. , 2000, Transplantation.

[2]  B. Davidson,et al.  A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. , 1999, Transplantation.

[3]  J. Prieto,et al.  Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  S. Negrini,et al.  A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. , 1999, Transplantation.

[5]  C. Margarit,et al.  Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  R. Calne,et al.  Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. , 1999, Transplantation.

[7]  H. Meier‐Kriesche,et al.  Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation , 1998 .

[8]  A. Louvel,et al.  Is acute rejection deleterious to long-term allograft function? , 1998 .

[9]  R. Wiesner,et al.  Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome , 1998, Hepatology.

[10]  J. Neuberger,et al.  What is the significance of acute liver allograft rejection? , 1998, Journal of hepatology.

[11]  L. Belli,et al.  Early cyclosporine monotherapy in liver transplantation: A 5‐year follow‐up of a prospective, randomized trial , 1998, Hepatology.

[12]  P. Mcmaster,et al.  Withdrawal of immunosuppression in liver allograft recipients. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[13]  B. Portmann,et al.  Defining the outcome of immunosuppression withdrawal after liver transplantation , 1998, Hepatology.

[14]  J. Contreras,et al.  Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. , 1998, Transplantation.

[15]  C. Lumbreras,et al.  Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients. , 1998, Journal of hepatology.

[16]  M. Stegall,et al.  Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. , 1997, Transplantation.

[17]  J. Soulillou,et al.  Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients , 1997, The Lancet.

[18]  P. Neuhaus,et al.  Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study. , 1997, Transplantation proceedings.

[19]  Randall G. Lee,et al.  Banff schema for grading liver allograft rejection: An international consensus document , 1997, Hepatology.

[20]  W. Bechstein,et al.  Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. , 1997, Clinical transplantation.

[21]  T. Starzl,et al.  Weaning of immunosuppression in liver transplant recipients. , 1997, Transplantation.

[22]  M. Stegall,et al.  Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss , 1997, Hepatology.

[23]  J. Buckels,et al.  Risk factors for liver rejection: evidence to suggest enhanced allograft tolerance in infancy. , 1996, Archives of disease in childhood.

[24]  A. Burroughs,et al.  Long-term immunosuppression without corticosteroids after orthotopic liver transplantation: a positive therapeutic aim. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  C. Chan,et al.  Cyclosporin A: Drug discontinuation for the management of long‐term toxicity after liver transplantation , 1996, Hepatology.

[26]  P. Ratcliffe,et al.  Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression , 1996, The Lancet.

[27]  F. Cosio,et al.  Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine. , 1996, Transplantation.

[28]  J. Barkun,et al.  Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients. , 1996, Transplantation proceedings.

[29]  L. Hilbrands,et al.  Costs of drugs used after renal transplantation , 1996, Transplant international : official journal of the European Society for Organ Transplantation.

[30]  L. Grande,et al.  Diabetes mellitus after liver transplantation: prevalence and predictive factors. , 1996, Journal of hepatology.

[31]  T. Therneau,et al.  Failed allografts and causes of death after orthotopic liver transplantation from 1985 to 1995: decreasing prevalence of irreversible hepatic allograft rejection. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[32]  A. Hoitsma,et al.  Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation. , 1996, Transplantation.

[33]  R. Busuttil,et al.  A randomized prospective trial of steroid withdrawal after liver transplantation. , 1995, Transplantation.

[34]  G. Opelz.  Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study. , 1995, Kidney international. Supplement.

[35]  M. Stegall,et al.  Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity. , 1995, Transplantation.

[36]  R. Merion,et al.  Corticosteroid withdrawal after liver transplantation. , 1995, Surgery.

[37]  L. Makowka,et al.  A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation: The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994;331:1110–1115 , 1995 .

[38]  C. Ponticelli,et al.  Corticosteroids in Kidney Transplant Recipients , 1995, Drug safety.

[39]  P. Schollmeyer,et al.  Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation. , 1995, Transplantation.

[40]  G. Tenderich,et al.  Long-term results with cyclosporine monotherapy after heart transplantation. , 1994, Transplantation proceedings.

[41]  W. Bechstein,et al.  Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. , 1994, Transplantation.

[42]  A. Demetris,et al.  Rejection and hepatitis in liver transplants. , 1994, Transplantation.

[43]  G. Gores,et al.  Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection , 1994, Hepatology.

[44]  H. Balfour,et al.  A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. , 1994, Transplantation.

[45]  D. Billmire,et al.  Monotherapy with cyclosporine for chronic immunosuppression in pediatric liver transplant recipients. , 1994, Transplantation.

[46]  P. Hudgins,et al.  Steroid withdrawal after pediatric liver transplantation. , 1994, Transplantation proceedings.

[47]  T. Starzl,et al.  Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. , 1994, Transplantation.

[48]  D. Hricik,et al.  Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. , 1993, Journal of the American Society of Nephrology : JASN.

[49]  D. Snydman.  Review of the efficacy of cytomegalovirus immune globulin in the prophylaxis of CMV disease in renal transplant recipients. , 1993, Transplantation proceedings.

[50]  R. Superina,et al.  Growth in children after liver transplantation on cyclosporine alone or in combination with low-dose azathioprine. , 1993, Transplantation proceedings.

[51]  T. Starzl,et al.  Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance , 1993, Hepatology.

[52]  G. Klintmalm,et al.  CAUSES OF LATE GRAFT LOSS AFTER LIVER TRANSPLANTATION , 1993, Transplantation.

[53]  J. Neuberger,et al.  Steroid withdrawal from long-term immunosuppression in liver allograft recipients. , 1993, Transplantation.

[54]  Sinclair Nr.  Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. , 1992 .

[55]  D. Hricik,et al.  Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients. , 1992, Transplantation.

[56]  D. Renlund,et al.  Corticosteroid-free maintenance immunosuppression after heart transplantation: feasibility and beneficial effects. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[57]  P. Macdonald,et al.  Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[58]  C. Margarit,et al.  Maintenance immunosuppression without steroids in pediatric liver transplantation. , 1989, Transplantation proceedings.